NCT/Study#
N/A /
CHECKPOINT-INHIBITOR
Analysis of Checkpoint Inhibitors as Post-Transplant Consolidation in Relapsed/Refractory and High-Risk Multiple Myeloma
DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
